Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2004
09/29/2004CN1532292A Transcription active test
09/29/2004CN1532291A High efficiency quick detection method of ligonucleotide library small fragment sequence
09/29/2004CN1532290A Path and method for monitoring non nucleotide reverse transcriptive enzyme inhibitor anti retrovirus therapy
09/29/2004CN1168988C Reagent test strip for blood glucose determination
09/29/2004CN1168987C Enzymological-test acetoacetic acid reagent kit
09/29/2004CN1168984C Double-parmeter cell period analysis method
09/29/2004CN1168836C Determination for specificity of candida albicans DNA sequence (3) and use thereof
09/29/2004CN1168835C Determination for specificity of Candida albicans DNA sequence (2) and use thereof
09/29/2004CN1168834C Determination for specificity of Candida albicans DNA sequence (5) and use thereof
09/29/2004CN1168833C Determination for specificity of candida albicans DNA sequence (4) and use thereof
09/29/2004CN1168832C Application of modified PCR amplified primer and its reagent box
09/29/2004CN1168827C Nucleotide specific to O-antigen of shigella boydii 7
09/29/2004CN1168826C Identifying probe and method for nucleotide sequence and nucleic acid molecule of red tide phaeocystis globosa
09/29/2004CN1168824C Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pulvialis for biosynthesis of astaxanthin
09/28/2004US6799122 Method for identifying polymorphic markers in a population
09/28/2004US6799119 Method for detection of biological related materials using biomarkers
09/28/2004US6797818 Methods for labeling nucleotides, labeled nucleotides and useful intermediates
09/28/2004US6797817 Nucleic acid fragments for the identification of dechlorinating bacteria
09/28/2004US6797812 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders
09/28/2004US6797811 Antibodies to chemokine receptor 88C
09/28/2004US6797696 Contacting a bodily fluid with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide to form a complex and detecting the complex; treating malignant neoplasms by inhibiting haah.
09/28/2004US6797524 Light-controlled electrokinetic assembly of particles near surfaces
09/28/2004US6797522 Solid phase synthesis; libraries; enzyme inhibitors; chromatography
09/28/2004US6797511 Basis of its ability to bind to presenilin 1; for treatment of alzheimer's disease
09/28/2004US6797509 Dna sequences from coryneform bacteria which encode a protein having transaldolase activity; for the fermentative production of l-amino acids
09/28/2004US6797502 Polypeptide for use in the treatment of hypertriglyceridemia, atherosclerosis and eating disorders
09/28/2004US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
09/28/2004US6797498 B, B-carotene 15, 15′-dioxygenases, nucleic acid sequences coding therefor and their use
09/28/2004US6797487 Polynucleotides encoding alzheimer's disease secretase
09/28/2004US6797486 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
09/28/2004US6797477 Genetic typing of the human cytochrome P450 2A6 gene and related methods
09/28/2004US6797475 Detection of polymorphisms in the human 5-lipoxygenase gene
09/28/2004US6797474 Rolling circle replication reporter systems
09/28/2004US6797472 For making treatment decisions for patients suffering from asthma and chronic obstructive pulmonary diseases (copd); pharmacogenomics
09/28/2004US6797471 Screening for tumors in humans; obtain sample, incubate with probes, monitoring abberations in hydridization pattern comparede to control
09/28/2004US6797470 Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
09/28/2004US6797468 For improving speed and sensitivity of polymerase chain reactions
09/28/2004US6797467 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions
09/28/2004US6797464 Detection of drug-resistant human immunodeficiency virus
09/28/2004US6797462 For determining host hiv titer, drug sensitivity, hiv amplification, gene sequencing and co-receptor utilization
09/28/2004US6797460 NMR-solve method for rapid identification of bi-ligand drug candidates
09/28/2004US6797263 Compositions and methods for achieving immune suppression
09/28/2004CA2333085C Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use
09/28/2004CA2321836C Automated molecular pathology apparatus having independent slide heaters
09/28/2004CA2301354C Low temperature expression cdnas encoding fructan synthesizing enzymes and method of isolating the same
09/28/2004CA2190282C Method for determination of cholesterol in low-density lipoprotein
09/28/2004CA2162557C Conserved motif of hepatitis c virus e2/ns1 region
09/25/2004CA2462343A1 Genetically biotinylated recombinant antibody in immunofiltration assay by light addressable potentiometric sensor for identification of venezuelan equine encephalitis virus
09/25/2004CA2461828A1 Lung cancer detection
09/23/2004WO2004081721A2 Method and apparatus for pattern identification in diploid dna sequence data
09/23/2004WO2004081566A2 Method and device for detecting biomolecules
09/23/2004WO2004081564A1 Expression profiling of tumours
09/23/2004WO2004081563A2 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a)
09/23/2004WO2004081537A2 Methods of evaluating caloric restriction and identifying caloric restriction mimetics
09/23/2004WO2004081535A2 The establishment of proteome structure profile databases and their uses
09/23/2004WO2004081534A2 Phosphokinase assay
09/23/2004WO2004081533A2 Vault and vault-like carrier molecules
09/23/2004WO2004081531A2 Ligand analysis
09/23/2004WO2004081530A2 Method and apparatus for environmental monitoring and bioprospecting
09/23/2004WO2004081521A2 Methods for direct detection of individual methotrexate metabolites
09/23/2004WO2004081520A2 Optically decodable microcarriers, arrays and methods
09/23/2004WO2004081235A1 Nucleic acid biosensors
09/23/2004WO2004081234A2 Dna analyzing apparatus, dna sensor, and analyzing method
09/23/2004WO2004081233A1 Diagnostic and prognostic compounds and method
09/23/2004WO2004081232A1 The method of in vitro detecting aberrant dysplasia, and the artificial nucleotides being used
09/23/2004WO2004081230A1 Method of evaluating activity of function factor reflecting physiologically active structural function and utilization of the same
09/23/2004WO2004081228A2 Real time gene expression profiling
09/23/2004WO2004081225A2 Amplification and analysis of whole genome and whole transcriptome libraries generated by a dna polymerization process
09/23/2004WO2004081224A2 Reca-assisted allele specific oligonucleotide extension method
09/23/2004WO2004081221A2 Pre-incubation method to improve signal/noise ratio of nucleic acid assays
09/23/2004WO2004081194A2 Approaches to identifying genetic traits in animals
09/23/2004WO2004081191A2 Molecular haplotyping of genomic dna
09/23/2004WO2004081187A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
09/23/2004WO2004081186A2 Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
09/23/2004WO2004081184A2 Markerless transformation
09/23/2004WO2004081183A2 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
09/23/2004WO2004081182A2 Compositions and methods for polynucleotide sequence detection
09/23/2004WO2004081181A2 Method for determining susceptibility of tumor to treatment with anti-neoplastic agent
09/23/2004WO2004081179A2 Regulation of rna stability
09/23/2004WO2004081177A2 Intracellular signaling pathways in diabetic subjects
09/23/2004WO2004081175A2 Methods and compositions for purification of nucleic acid from a host cell
09/23/2004WO2004081174A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
09/23/2004WO2004081050A1 Antibody against tumor specific antigen as target
09/23/2004WO2004081041A1 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof
09/23/2004WO2004081039A1 Novel protein and its dna
09/23/2004WO2004081033A2 Synthesis of proteins by cell-free protein expression
09/23/2004WO2004080535A2 Methods and compositions for treating aids and hiv-related disorders using 9145, 1725, 311, 837, 58305, 156, 14175, 50352, 32678, 5560, 7240, 8865, 12396, 12397, 13644, 19938, 2077, 1735, 1786, 10220, 17822, 33945, 43748, 47161, 81982, or 46777
09/23/2004WO2004080448A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases
09/23/2004WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth
09/23/2004WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
09/23/2004WO2004080406A2 Therapeutic compositions
09/23/2004WO2004080392A2 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
09/23/2004WO2004080378A2 Methods and tools for screening active rna in cellulo
09/23/2004WO2004080374A2 Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c)
09/23/2004WO2004080285A2 Amyloid plaque as a target for therapeutics that function by blocking or disrupting chitin synthesis or activity
09/23/2004WO2004080273A2 Compositions and methods for diagnosing and treating prostate cancer
09/23/2004WO2004080272A2 Use of the genes leprotl1 and ob-rgrp for the screening of active compounds for weight gain or loss or diabetes in human or animal subjects
09/23/2004WO2004080271A2 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
09/23/2004WO2004080270A2 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1b (pde1b)
09/23/2004WO2004080202A2 Production of plants with improved digestibility having an inactive peroxidase